We previously observed that Pim-3 with serine/threonine kinase activity, was aberrantly expressed in malignant lesions of endodermderived organs, liver and pancreas. Because Pim-3 protein was not detected in normal colon mucosal tissues, we evaluated Pim-3 expression in malignant lesions of human colon, another endodermderived organ. Pim-3 was detected immunohistochemically in welldifferentiated ( 
P im-3 was originally identified as the depolarization-induced gene, KID-1, in PC12 cells, a rat pheochromocytoma cell line.
(1) Because KID-1 shows a high sequence similarity with the proto-oncogene Pim family that expresses serine/threonine kinase activity, it was renamed as Pim-3. (2) Accumulating evidence indicates the potential involvement of other Pim family members, Pim-1 and Pim-2, in various types of carcinogenesis. (3) (4) (5) (6) Indeed, Deneen and colleagues demonstrated that Pim-3 gene transcription was enhanced in EWS/ETS-induced malignant transformation of NIH 3T3 cells. (7) Moreover, we revealed that Pim-3 was selectively expressed in malignant lesions but not normal tissues of endoderm-derived organs, liver (8) and pancreas. (9) These observations suggest the potential involvement of Pim-3 in carcinogenesis, particularly in endoderm-derived organs.
Apoptosis is an important mechanism during normal crypt formation in another endoderm-derived organ, colon. (10) The molecular mechanism of colon cancer progression is known to involve several key events and mutation of a number of crucial genes. (11) A partial suppression of apoptosis occurs as a result of the inactivation of both alleles of the APC gene and the suppression of apoptosis allows APC-deficient cells to develop adenomatous polyps. (12) Further suppression of apoptosis occurs as these cells develop additional genetic mutations and phenotypic changes. (13) Thus, the dysregulation of apoptosis is crucially involved in colon carcinogenesis.
Accumulating evidence indicates that Pim kinases can phosphorylate substrates that regulate apoptosis, and that activated Pim kinases might contribute to the pathogenesis of a wide variety of malignancies. (14) Similarly, as observed on other members of Pim family, (15, 16) we demonstrated that aberrantly expressed Pim-3 can inactivate a pro-apoptotic BH3-only Bcl-2-like molecule, Bad, by phosphorylating its serine residue and eventually prevent apoptosis in human pancreatic cancer cell lines. (9) These observations suggest that Pim-3 may contribute to carcinogenesis by negatively modulating apoptosis.
Our previous northern blotting analysis failed to detect Pim-3 mRNA in normal human endoderm-derived organs including liver, pancreas and colon. (8) Given that Pim-3 can prevent apoptosis, we assumed that Pim-3 might be aberrantly expressed in malignant lesions of the colon and might contribute to colon carcinogenesis. To address this hypothesis, we examined Pim-3 expression in human colon cancer tissues and found that Pim-3 protein was detected in a substantial portion of human colon cancer samples, particularly at the less advanced stages of cancer development. Moreover, the ablation of endogenous Pim-3 in the colon cancer cell line reduced the amount of phosphorylated Bad and eventually promoted apoptosis. Furthermore, we demonstrated that Pim-3 was co-localized with Bad in cancer cells in human colon cancer tissues. Cell culture. A well-differentiated colon cancer-derived cell line, SW480 (17) was maintained in RPMI-1640 medium (Sigma Chemical); while a moderately differentiated colon cancer-derived cell line, HT29, (18) and a poorly differentiated cell line, HCT116 (19) were maintained in McCoy's 5 A Modified Medium (Invitrogen, Carlsbad, CA, USA). The media were supplemented with 10% heat-inactivated fetal bovine serum (FBS, Atlanta Biologicals, Norcross, GA, USA) and the cells were incubated in a humidified incubator at 37°C in 5% CO 2 .
Materials and methods
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Paraffin-embedded human colon adenocarcinoma tissues were deparaffinized in xylene, rehydrated through graded concentrations of ethanol and washed with phosphate-buffered saline (PBS). Endogenous peroxidase activity was blocked with 3% H 2 O 2 (DakoCytomation, Carpinteria, CA, USA) for 5 min. For antigen retrieval, sections were heated in 10 mM sodium citrate buffer (pH 6.0), followed by blocking with Non-Specific Staining Blocking reagent (DakoCytomation). The slides were incubated with rabbit polyclonal anti-Pim-3 IgG (3 µg/mL) or with normal rabbit IgG overnight at 4°C. Immunofluorescence analyses. Cells were seeded on LaboratoryTeck chamber slides (Nalge Nunc International, Naperville, IL, USA) and incubated at 37°C with 5% CO 2 . Forty-eight hours later, they were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100/PBS for 10 min. Immunostaining was performed by incubating the slides with rabbit polyclonal anti-Pim-3 (3 µg/mL), or with the combination of mouse antiBad (1:30) and rabbit anti-Hsp60 antibodies (1:200), followed by incubation with Alexa Fluor 488 donkey anti-rabbit and/or Alexa Fluor 594 donkey anti-mouse (1:100) fluorescent antibodies for 1 h at room temperature. As a negative control, slides were incubated with normal donkey serum instead of the primary antibodies. In some experiments, after washing with PBS, cells were incubated with propidium iodide (Annexin V-FITC kit, Bender MedSystems, GmbH, Vienna, Austria; 1 µg/mL) for 1 min. Images were captured on a Carl Zeiss LSM510 confocal microscope (Carl Zeiss Microimage, Thornwood, NY, USA).
Immunoprecipitation and western blotting. Human colon tissues were minced into small pieces and homogenized in RIPA Lysis buffer (Santa Cruz Biotechnology), supplemented with protease inhibitors. The lysates were sonicated and centrifuged at 20 800 g at 4°C for 15 min. The resultant cell lysates were used for western blotting with anti-Pim-3 IgG as previously described. (9) Cell lysates from colon cancer cell lines were subjected to immunoprecipitation with anti-Pim-3 IgG followed by western blotting analysis with anti-Pim-3 IgG as previously described. (9) Cell lysates immunoprecipitated with control rabbit IgG were used as a negative control, while those from HEK293 cells transfected with human Pim-3 cDNA were used as a positive control. In some experiments, mouse anti-Bad antibody (1:100) was used instead of anti-Pim-3 antibody in western blot analyses following immunoprecipitation with anti-Pim-3 antibody.
Transfection with short hairpin RNA (shRNA). SW480, HT29 and HCT116 cells were transfected with shRNA for Pim-3 (5′-GCACGUGGUGAAGGAGCGG-3′) and Scramble shRNA (5′-GCGCGCUUUGUAGGAUUCG-3′), inserted into the pSilencer 3.1-H1 Neo expression vector (Ambion, Austin, TX, USA), using Lipofectamine 2000 Reagent (Invitrogen) according to the manufacturer's instructions. In our preliminary experiments, Pim-1 and Pim-2 mRNA was faintly detected in SW480, HT29 and HCT116 cells. However, we further confirmed that the transfection of Pim-3 shRNA reduced the mRNA expression of Pim-3, but not Pim-1 and Pim-2 (data not shown).
Cell cycle and cell apoptosis analysis. At the indicated time intervals following the transfection with either Pim-3 or Scramble shRNA, the cells were harvested and fixed with 70% ethanol at −20°C. The fixed cells were incubated with 50 µg/mL propidium iodide (Molecular Probes) and 1 µg/mL RNase A for 30 min at room temperature. DNA content was then analyzed on a FACS Calibur system (Becton Dickinson, Bedford, MA, USA). The distribution of cells in each cell-cycle phase was determined by using cell ModFitLT Software (Becton Dickinson). In some experiments, phosphatidylserine exposure level was determined by staining the cells with human Annexin V-FITC Kit (Bender MedSystem GmbH, Vienna, Austria), according to the manufacturer's instructions. At least 20 000 stained cells were analyzed on a FACS Calibur system for each determination.
Determination of Bad proteins after Pim-3 shRNA transfection.
At the indicated time intervals following shRNA transfection, whole cell lysates were prepared by using CelLytic-M mammalian Cell Lysis/ Extraction Reagent containing complete protein inhibitor cocktail as previously described. (9) Aliquots (50 µg) of the obtained supernatants were separated by 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto an Immobilon-P Transfer membrane. After being saturated with 3% bovine serum albumin (BSA), the membrane was incubated with rabbit anti-Pim-3, mouse anti-Bad, rabbit anti-phopho-Ser 112 Bad, antiphospho-Ser 136 Bad, or anti-phophoSer Statistical analysis. The data on human colon carcinoma tissues were analyzed statistically by using Spearman's correlation analysis to analyze the rank data. P < 0.05 was accepted as statistically significant.
In other experiments, data were expressed as mean ± SD and analyzed by using one-way anova, followed by Fisher's protected least significant difference test. Differences were considered significant, when P < 0.05.
Results
Enhanced Pim-3 protein expression in human colon cancer tissues.
Pim-3-positive cells were not detected in colon tissues that lacked any malignant lesions (data not shown), or normal colon epithelium distant to adenocarcinoma (Fig. 1A-a) . In contrast, a substantial number of Pim-3-positive cells were detected in normal epithelium adjacent to adenocarcinoma tissues (Fig. 1A-b) or adenoma tissues (Fig. 1A-c) , as well as adenocarcinoma ( Figs 1A-d,e) . The positive reaction was not observed when control IgG was used as the primary antibody instead of anti-Pim-3 antibodies (Fig. 1B) , indicating the specificity of the reaction. Pim-3 protein was detected mainly in the cytoplasm of adenoma and adenocarcinoma cells (Fig. 1A-c-e) . Moreover, western blotting analysis detected Pim-3 protein in tumor but not normal colon tissue derived from a patient with well-differentiated colon carcinoma (Fig. 1C) , further indicating the specificity of the used antibody. Although some adenocarcinoma tissues consisted mostly of Pim-3-positive cells (Fig. 1A-d) , positive rates were the highest in adenoma (Table 1) . Poorly differentiated adenocarcinoma (n = 5) did not show any positive staining (Fig. 1A-f ), while well-and moderately differentiated adenocarcinoma exhibited similar Pim-3 staining (Figs 1A-c,d, Table 2 ). Moreover, tumor sizes and invasive depth did not have any significant effects on the extent of Pim-3 staining (Table 2 ). In contrast, the presence of lymph node or liver metastatic foci resulted in decreased Pim-3 expression, compared with adenocarcinoma without a distant metastasis (Table 2) . When 60 samples from a different group were simultaneously analyzed for Pim-3 expression in both primary foci and metastatic lesions, Pim-3 expression in primary foci did not show any significant correlation with that in metastatic foci (Table 3 ). These observations suggest that Pim-3 expression was enhanced more frequently at the early phase rather than the later stages of colon carcinogenesis when distant metastasis occurs.
Constitutive Pim-3 expression in human colon cancer cell lines.
Pim-3 expression in colon cancer tissues prompted us to examine Pim-3 expression in colon cancer-derived cell lines, SW480, HT29 and HCT116, which are derived from well-, moderately, and poorly differentiated cancer cells. Reverse transcription polymerase chain reaction (RT-PCR) analysis detected Pim-3 mRNA in these cell lines (data not shown). Immunoblotting analysis demonstrated that SW480 and HT29 contained similar but greater amounts of Pim-3 than HCT116 (Fig. 2a,b) . An immunofluorescence analysis further demonstrated a lower Pim-3 expression in HCT119, compared with SW480 and HT29 (Fig. 2c ), consistent with a lower incidence of Pim-3 expression in human poorly differentiated colon cancer (Table 2) . Because Pim-3 can inactivate a pro-apoptotic BH3-only protein, Bad by phosphorylating Ser 112 , (9) we examined the phosphorylation states of Bad in these cell lines. Bad was constitutively phosphorylated at Ser 112 and to a lesser degree, Ser 136 and Ser 155 in these cell lines. Furthermore, the amounts of total Bad and phospho-Ser 112 Bad, but not other phosphorylated forms of Bad, were higher in SW480 and HT29 than HCT116 cells (Fig. 2a,b) . (Fig. 3a) . The transfection of Pim-3 shRNA resulted in a higher ratio of sub-G1 cell populations with reduced G1 and G2/ M (Fig. 3bi-iii) . Moreover, Pim-3 shRNA transfectants contained a markedly higher ratio of apoptotic cells as evidenced by enhanced phosphatidylserine externalization ( Fig. 3biv-vi) . Similar phenomena were observed when HT29 cells were transfected with Pim-3 shRNA (data not shown). We next examined the effects of Pim-3 ablation on Bad phosphorylation. The ablation of Pim-3 reduced the amount of phospho-Ser 112 Bad but not the amounts of total Bad and phospho-Ser 136 Bad (Fig. 3a) . Several lines of evidence indicate that Bad was translocated from cytoplasm to mitochondria upon its dephosphorylation. (20) Hence, we explored the intracellular localization of Bad upon dephosphorylation of Ser 112 but Ser
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Bad arising from Pim-3 ablation. We employed anti-Hsp60 antibodies to detect mitochondria, because Hsp60 is exclusively present in mitochondria. (21) Bad was not co-localized with Hsp60 in untreated cells but Pim-3 ablation induced the co-localization of Bad with Hsp60 (Fig. 3c) , suggesting its mitochondrial localization. Similar phenomena were observed on another colon cancer cell line, HT29 (data not shown). Thus, these observations suggest that Pim-3, aberrantly expressed in human colon cancer cells, can inactivate the potent pro-apoptotic factor, Bad, and thereby prevent its translocation to mitochondria, by phosphorylating Bad Ser 112 .
Co-localization of Pim-3 with Bad protein in primary human colon cancer. In order to address whether there was evidence to suggest that Pim-3 might phosphorylate Bad in primary human colon cancer cells, we performed a double-color immunofluorescence analysis on human colon cancer tissues. Pim-3 protein was detected in tumor cells in 9/10 human colon cancer samples that we examined. In all these Pim-3-positive samples, Bad protein was co-localized with Pim-3 proteins in both the horizontal (xy axis) and orthogonal planes (xz and yz axes) (Fig. 4a) . Pim-3 proteins did not co-localize with glyceraldehyde-3-phosphate dehydrogenase Proportion of Pim-3-positive cells were evaluated in mucosa and adenoma, that are adjacent to adenocarcinoma, as well as the adenocarcinoma area, as described in Materials and Methods. *, compared with adenoma, P = 0.001, Spearman's rank correlation coefficient (Rs) = 0.596; **, compared with adenocarcinoma, P = 0.008; Rs = 0.202; ***, compared with mucosa, P = 0.001, Rs = 0.347. (GAPDH), a protein that is abundantly present in the cytoplasm (data not shown). Moreover, an immunoprecipitation with anti-Pim-3 antibodies co-precipitated Bad in a human colon cancer tissue (Fig. 4b ). These observations would further indicate the co-localization of Pim-3 with Bad in human colon cancer cells. Finally, in 6/9 Pim-3-positive samples, Pim-3 protein co-localized with phospho-Ser 112 Bad in both the horizontal (xy axis) and orthogonal planes (xz and yz axes) (Fig. 4c) . Thus, Pim-3 may phosphorylate Bad at Ser 112 even in primary colon cancer, thereby regulating apoptosis of the cancer cells.
Discussion
Orderly apoptosis of colon epithelial cells is essential for normal colon crypt formation. (10) A partial deregulation of apoptosis occurs due to the inactivation of both alleles of the APC gene, the first key event in colon carcinogenesis. (12) Further suppression of apoptosis occurs as these cells develop additional genetic mutations and phenotypic changes. (13) However, the molecular mechanisms underlying apoptosis deregulation in colon carcinogenesis remain elusive. Accumulating evidence suggests that the regulation of apoptosis of colon cancer cells involves several kinases including Erk1/2, p38 mitogen-activated kinase, and Akt. (22) (23) (24) (25) (26) Pim kinases can phosphorylate a similar range of substrates as Akt and thus can provide survival signals to various types of tumor cells. (14) Our observation that Pim-3 expression was enhanced in the malignant lesions of endodermderived organs, the liver (8) and pancreas, (9) prompted us to evaluate Pim-3 expression in colon carcinoma tissue. Indeed, Pim-3 was expressed in a substantial portion of primary colon cancer tissues. Moreover, we have determined that aberrantly expressed Pim-3 may counteract apoptosis by phosphorylating a pro-apoptotic molecule, Bad.
Another member of the Pim family, Pim-1, becomes constitutively active without any alteration in conformation, due to the absence of any regulatory domains. (27) Pim-3 shows a high sequence identity with Pim-1, even in the kinase domain and lacks any regulatory domains. (8) Thus, when aberrantly expressed in colon cancer cells, Pim-3 can be active without any further modification. Recently, the human Pim-3 gene has been assigned to chromosome 22q13. A comparative genomic hybridization analysis demonstrated that the gain at 22q13.3 represented the minimal chromosomal changes found specifically in colon cancer tissues with microsatellite instability.
(28) However, we failed to detect Pim-3 gene amplification in several human colon cancer cell lines including SW480 and HT29 (unpublished data). Thus, it is not likely that constitutive enhanced expression of Pim-3 in colon cancer cells is a result of Pim-3 gene amplification.
Several lines of evidence suggest that a transcription factor, Stat3, is constitutively activated in colon cancer (29) (30) (31) and that both Pim-1 and Pim-2 can be a transcriptional target of Stat3. (32, 33) Moreover, we also observed that the transfection of a dominant negative form of Stat3 reduced Pim-3 expression in SW480 cells (unpublished data), suggesting that Stat3 can regulate Pim-3 gene transcription. Of interest is that Pim-1 can synergistically induce Stat3-mediated cell cycle progression and anti-apoptotic process. (32) Aberrantly expressed Pim-3 may also synergistically augment the Stat3-induced malignant phenotype of colon cancer as Pim-3 has a remarkable sequence identity with Pim-1. If this is indeed the case, blocking Pim-3 activity may reduce Stat3 activity and thus inhibit colon cancer progression.
Akt shows a similar substrate specificity as the Pim kinases including Pim-3 and is presumed to have an essential role in the regulation of apoptosis. (14) Activation of Akt can contribute to the pathogenesis of a wide variety of malignancies. Indeed, Roy et al. demonstrated that activated Akt was detected in a substantial portion of colon adenoma (57% positive) and adenocarcinoma (57% positive) but not in normal colonic epithelium and hyperplastic polyps. (25) Based on these observations, these authors claimed that Akt overexpression may be an early event during colon carcinogenesis. Pim-3 exhibited a similar staining pattern as Akt. Pim-3 was also detected in normal colon mucosal tissues that are adjacent to adenocarcinoma but do not exhibit any morphological abnormalities. Thus, Pim-3 overexpression might be an earlier event than that of Akt during the development of the malignant phenotype. Moreover, the incidence of Pim-3 expression was higher in adenoma than adenocarcinoma. We previously observed that precancerous lesions in liver showed a higher incidence of Pim-3 expression than hepatocellular carcinoma lesions. (8) Thus, it is tempting to speculate that aberrant Pim-3 expression might generally have a crucial role in the early phase but not later phase of carcinogenesis.
Genetic analysis has revealed that somatic missense mutations in the gene of Bad, a pro-apoptotic BH3-only protein, occur in a small proportion of colon adenocarcinoma samples. (34) It was postulated that somatic mutation of Bad may contribute to colon 
